CD8A and neoplasm: Local co-delivery of CDG with ICIs expanded the repertoire of tumor-infiltrating CD8+ T cells and elevated the proportion of stimulator of prostatic adenocarcinoma specific (SPAS)-specific T cells, thereby broadening antitumor immunity and enhancing responses to subdominant tumor antigens.